Cardiology News and Research

Latest Cardiology News and Research

Heart transplant recipients affected by COVID-19 face racial, gender disparities

Physician-scientists specializing in heart failure wanted to know: if their heart transplant patients contract COVID-19, would they have a different experience than the general public or others who are also immunosuppressed?

9 Jun 2020

When a doctor no longer accepts Medicare, patients left holding the bag

Pneumonia. Heart problems. High cholesterol. Betsy Carrier, 71, and her husband, Don Resnikoff, 79, relied on their primary care doctor in Montgomery County, Maryland, for help managing their ailments.

9 Jun 2020

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

Empagliflozin (EMPA), a selective inhibitor of sodium/glucose cotransporter 2 (SGLT2 inhibitors, "gliflozines"), reduces CKD progression in type 2 diabetics (T2D) with cardiovascular disease, presumably by lowering intraglomerular pressure.

9 Jun 2020

COVID-19 produces lung inflammation in non-human primate experiments

A new study published on the online preprint server bioRxiv in June 2020 reports the successful use of three primate species to model the infection, pathogenesis, and clinical features associated with COVID-19. The research provides useful and immediately available models to test new vaccines and treatments.

9 Jun 2020

Metabolic diseases alter ACE2 expression and increase COVID-19 severity

A new study published on the preprint server medRxiv in June 2020 reports that one mechanism for this variable severity is the differential expression of the ACE2 receptor in various metabolic conditions, thereby facilitating viral entry into the host cells.

9 Jun 2020

New syndrome associated with SARS-CoV-2 is new and distinct from Kawasaki disease

A study on children suffering from severe inflammatory symptoms shows the condition is new and distinct from Kawasaki disease.

8 Jun 2020

Health disparities negatively impact various groups of people

Certain illnesses and diseases have the ability to affect various groups of people in detrimental ways.

8 Jun 2020

Mount Sinai receives award from Microsoft AI for Health to support COVID Informatics Center

The Mount Sinai Health System has received an award from Microsoft AI for Health to support the work of a new data science center dedicated to COVID-19 research.

8 Jun 2020

Heart damage among hospitalized COVID-19 patients linked to higher risk of mortality

Mount Sinai researchers have found that myocardial injury (heart damage) is prevalent among patients hospitalized with COVID-19 and is associated with higher risk of mortality.

8 Jun 2020

Improving detection of SARS-CoV-2 infection among severely ill children

Researchers in the UK have conducted a study showing that children with a severe inflammatory syndrome had high levels of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), despite having tested negative for the virus by polymerase chain reaction (PCR).

8 Jun 2020

Georgia State researcher receives $1.95 million NIH grant to study cause of autoimmunity

Dr. Leszek Ignatowicz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $1.95 million federal grant to study what causes autoimmunity in the human body.

8 Jun 2020

Virginia Tech researcher develops new ‘fat burning’ molecule with potential to treat obesity

Obesity affects more than 40 percent of adults in the United States and 13 percent of the global population.

8 Jun 2020

Incidence of intracerebral hemorrhages increasing in older people, study finds

Brain bleeds called intracerebral hemorrhages remained stable in incidence among all age groups over the past 30 years, but they increased in people 75 and older, according to a new analysis of the Framingham Heart Study. The findings are in JAMA Neurology.

8 Jun 2020

Novel compound shows promise for ANCA-associated vasculitis

ANCA-associated vasculitis (AAV) is a systemic disease involving the formation of special autoantibodies (so-called anti-neutrophil cytoplasmic antibodies/ANCA) and vascular inflammation.

8 Jun 2020

Study identifies potential biomarker for prescreening donor's stem cells

A new study released today in STEM CELLS addresses a significant problem that has been confronting human mesenchymal stem cells (hMSCs) therapy.

8 Jun 2020

Gene expression may be a decisive factor for controlling possible comorbidities

A study led by the Barcelona Supercomputing Center, in which the Universitat de València participates, concludes that the specific characteristics of each patient, such as gene expression, may be a decisive factor in the development of clinical strategies aimed at addressing and controlling possible comorbidities.

8 Jun 2020

Blood pressure medications offer survival benefit for even the frailest elderly people

Taking blood pressure medication as prescribed helped even the frailest elderly people (65 and older) live longer, and the healthiest older people had the biggest survival boost, according to a large study in northern Italy published today in Hypertension, an American Heart Association journal.

8 Jun 2020

Bystander CPR benefits outweigh the risks of COVID-19 infection

Analysis of Seattle emergency medical services and hospital data from January 1 to April 15, 2020, indicates bystander CPR is a lifesaving endeavor whose benefits outweigh the risks of COVID-19 infection, according to a new article published yesterday in the American Heart Association's flagship journal Circulation.

5 Jun 2020

Sleep fragmentation associated with inflammation and atherosclerosis

Disrupted nightly sleep and clogged arteries tend to sneak up on us as we age. And while both disorders may seem unrelated, a new study from the University of California, Berkeley, helps explain why they are, in fact, pathologically intertwined.

5 Jun 2020

European database investigates COVID-19 outcomes in patients with kidney failure

Experience throughout the world, including in Europe, shows that advanced age is the most important risk factor for death in COVID-19: people aged over 70 years are over 10 times more likely to die compared to those aged below 50.

5 Jun 2020

Cardiology News and Research

Latest Cardiology News and Research

Heart transplant recipients affected by COVID-19 face racial, gender disparities

When a doctor no longer accepts Medicare, patients left holding the bag

Empagliflozin reduces CKD progression in type 2 diabetics with cardiovascular disease

COVID-19 produces lung inflammation in non-human primate experiments

Metabolic diseases alter ACE2 expression and increase COVID-19 severity

New syndrome associated with SARS-CoV-2 is new and distinct from Kawasaki disease

Health disparities negatively impact various groups of people

Mount Sinai receives award from Microsoft AI for Health to support COVID Informatics Center

Heart damage among hospitalized COVID-19 patients linked to higher risk of mortality

Improving detection of SARS-CoV-2 infection among severely ill children

Georgia State researcher receives $1.95 million NIH grant to study cause of autoimmunity

Virginia Tech researcher develops new ‘fat burning’ molecule with potential to treat obesity

Incidence of intracerebral hemorrhages increasing in older people, study finds

Novel compound shows promise for ANCA-associated vasculitis

Study identifies potential biomarker for prescreening donor's stem cells

Gene expression may be a decisive factor for controlling possible comorbidities

Blood pressure medications offer survival benefit for even the frailest elderly people

Bystander CPR benefits outweigh the risks of COVID-19 infection

Sleep fragmentation associated with inflammation and atherosclerosis

European database investigates COVID-19 outcomes in patients with kidney failure

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cardiology News and Research

Latest Cardiology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in